-+ 0.00%
-+ 0.00%
-+ 0.00%

Allarity Therapeutics Q3 EPS $(0.19) Beats $(0.21) Estimate

Benzinga·11/14/2025 14:11:21
Listen to the news
Allarity Therapeutics (NASDAQ:ALLR) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.21) by 9.52 percent. This is a 97.54 percent increase over losses of $(7.71) per share from the same period last year.